This work investigates the complex relationship between pulmonary hypertension and myeloproliferative neoplasms. The study presents the largest analysis to date on this correlation, specifically examining the link between JAK-2 allele burden and pulmonary hypertension. It includes a concise review of myeloproliferative neoplasms, pulmonary hypertension, and the JAK-2 allele mutation before detailing the study's findings, which indicate no correlation between JAK-2 allele burden and pulmonary hypertension, though pulmonary hypertension was found in 12% of the cases studied.

This study represents a significant contribution to the understanding of pulmonary hypertension in the context of myeloproliferative neoplasms, particularly through its novel investigation into the JAK-2 allele burden. The research provides valuable data on the prevalence of the condition within this patient group. The findings suggest that while pulmonary hypertension is present in a notable percentage of cases, it does not appear to correlate with the JAK-2 allele burden, offering a specific insight for further clinical consideration.